 The end-result is a B cell that is able to mass-produce specific antibodies against an antigenic target.Early evidence for these effects were that in CD40 or CD154 deficient mice, there is little class switching or germinal centre formation, and immune responses are severely inhibited.The expression of CD40 is diverse.